Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,078 shares of the healthcare conglomerate’s stock, valued at approximately $5,098,000. UnitedHealth Group accounts for about 1.3% of Point72 Asia Singapore Pte. Ltd.’s investment portfolio, making the stock its 11th largest holding.
A number of other hedge funds have also added to or reduced their stakes in UNH. Norges Bank bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $6,375,744,000. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi increased its stake in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC lifted its position in shares of UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
UNH has been the topic of a number of research reports. Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Mizuho lifted their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Robert W. Baird lowered their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research report on Wednesday. Six analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $523.52.
UnitedHealth Group Stock Performance
NYSE UNH opened at $308.35 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $284.25 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s fifty day moving average is $478.83 and its two-hundred day moving average is $517.83. The firm has a market capitalization of $279.72 billion, a P/E ratio of 19.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the firm earned $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.72%. UnitedHealth Group’s payout ratio is currently 35.18%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is a Special Dividend?
- Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
- The Significance of Brokerage Rankings in Stock Selection
- Blade Mobility Stock Soars—Is This SPAC Finally Taking Off?
- Differences Between Momentum Investing and Long Term Investing
- Is It Time to Buy the Dip in Novo Nordisk Stock?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.